ISRCTN17941313已完成未知
COVID-19: Determining trustworthiness and safety of REmote Consulting in primary Healthcare for chronic disease populations in Nigeria and Tanzania using a stepped wedge design - The REaCH Trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 12,022
研究概览
简要总结
2023 Abstract results in https://doi.org/10.1016/j.diabres.2023.110484 Abstracts from the IDF World Diabetes Congress 2022 - 0837 (added 07/06/2023) 2023 Results article in https://doi.org/10.1016/s2214-109x(23)00411-4 (added 20/10/2023)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Receiving healthcare from participating primary care facilities
- •2. Able to speak, read and write in English or local language
- •3. Give consent to participate in the study
- •4. Aged =18 years
- •5. Receiving treatment and/or monitoring for =1 of the following conditions:
- •5.1. Type 2 diabetes
- •5.2. Hypertension
- •5.3. Chronic obstructive pulmonary disease
- •5.4. Coronary heart disease
- •6. Contact with health facility =3 times per year
排除标准
- •1. No access to a mobile phone or fixed phone in the community
- •2. Identified by health workers as nearing the end of life or currently severely ill
- •3. Carers consulting on another person’s behalf
- •4. Unable to provide informed consent
研究者
相似试验
已完成
2 期
Evaluation of Alisporivir for the Treatment of Hospitalised Patients With Infections Due to SARS-CoV-2 (COVID-19)SARS-CoV-2NCT04608214Assistance Publique - Hôpitaux de Paris26
已完成
不适用
Monitoring the Effectiveness and Safety of COVID-19 Vaccines at National University of ColombiaCovid19SARS-CoV2 InfectionNCT04887246Universidad Nacional de Colombia4,078
已完成
2 期
A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor TherapySolid Tumor MalignancyHematologic MalignancyMultiple MyelomaLeukemiaLymphomaNCT04847050National Cancer Institute (NCI)19
招募中
2 期
Immunogenicity and the safety of the COVID-19 vaccines available in Thailand.The immune response after COVID-19 vaccine administration in healthy volunteers.COVID-19 vaccine, Sputnik V, ChAdOx1, coronavac, Sinovac.TCTR20210517006Chulabhorn Royal Academy3,000
已完成
4 期
Studies of COVID-19 Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol)DiarrheaCOVID-19NCT04811339University of Cincinnati60